SIBO - Small Intestinal Bacterial Overgrowth
  • Welcome
  • About SIBO
    • Overview
    • Symptoms
    • Associated Diseases
    • Testing
  • Treatment
    • Overview
    • Antibiotics
    • Herbal Antibiotics
    • Elemental Formula
    • Diet
    • Prevention of Relapse
  • Learning More
  • Studies
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2009
    • 1990's
    • 1980's
  • Resources
    • Finding a Doctor
    • Testing
    • Handouts
    • Books
    • Cookbooks
    • Diet/Recipe Websites
    • Apps
    • Discussion Groups
    • Podcasts
    • MMC Videos
    • Elemental Diet Videos
  • Contact
    • About Dr. Siebecker
    • Skype Consultations

2019 Research Articles

Overview
  • The Spectrum of Small Intestinal Bacterial Overgrowth (SIBO).  PMID: 30645678
  • Small Intestinal Bacterial Overgrowth: Clinical Features and Therapeutic Management.  PMID: 31584459
  • Small Intestinal Bacterial Overgrowth in Children: A State-Of-The-Art Review.  PMID: 31552207
  • Small Intestinal Bacterial Overgrowth.  PMID: 31536241
  • Is A Real Condition?  PMID: 31550680  
 
Pathophysiology 
  • Infection-Induced Intestinal Dysbiosis Is Mediated by Macrophage Activation and Nitrate Production.  PMID: 31138751
  • Mo1615 – Fat-Soluble Vitamins, B12, and Iron Deficiency in Patients with Coliform Small Intestinal Bacterial Overgrowth.  DOI: 10.1016/S0016-5085(19)38959-0
  • 4 – First Large Scale Study Defining the Characteristic Microbiome Signatures of Small Intestinal Bacterial Overgrowth (SIBO): Detailed Analysis from the Reimagine Study.  DOI: 10.1016/S0016-5085(19)36776-9
  • Sa1755 – Presenting Symptom Severity and Health-Related Quality of Life Do Not Predict Lactulose Breath Test Outcomes in Patients with Suspected Small Intestinal Bacterial Overgrowth.  DOI: 10.1016/S0016-5085(19)37822-9
  • Sa1911 – Analysis of the Small Intestinal Microbiome Reveals Marked Differences from Stool Microbiome in a Large Scale Human Cohort: Redefining the “Gut Microbiome”.  DOI: 10.1016/S0016-5085(19)37977-6   
  • Carbohydrate Intolerance and Disaccharidase Measurement - a Mini-Review.  PMID: 31857738  ​

Causes/ Risk Factors
 
   Appendicitis  NEW
  • 1149 – Microbial Sequencing of the Appendiceal Microbiome Reveals Elevated Levels of C. Jejuni in Acute Appendicitis  doi: 10.1016/S0016-5085(19)37416-5
   Biofilm
  • 443 – Intestinal Biofilms are an Endoscopic Feature of Irritable Bowel Syndrome.  DOI: 10.1016/S0016-5085(19)37016-7
   Diseases
  • Increased fasting small-bowel water content in untreated coeliac disease and scleroderma as assessed by magnetic resonance imaging.  PMID: 31839961
    Food Poisoning
  • Sa1954 – Post Infection IBS (PI-IBS) is Very Infrequent in Mexico and Patients Have Similar Characteristics Than Those with Non Pi-Ibs Ones.  DOI: 10.1016/S0016-5085(19)38020
   PPI's/Hypochlorhydria 
  • Bowel symptoms in patients that receive proton pump inhibitors. Results of a multicenter survey in Mexico.  PMID: 29678362
  • 979 – A Large Scale Evaluation of the Small Intestinal Microbiome in Subjects on Proton Pump Inhibitors.  DOI: 10.1016/S0016-5085(19)37311-1
   Surgery
  • Lactulose Breath Testing Can Be a Positive Predictor Before Weight Gain in Participants with Obesity Submitted to Roux-en-Y Gastric Bypass.  PMID: 31187458
  • Small intestinal bacterial overgrowth is common after gastrectomy but with little impact on nutritional status.  DOI: 10.1016/j.gastre.2019.01.007
  • Bariatric Surgery and Its Complications in Inflammatory Bowel Disease Patients.  PMID: 31626698
  • Partially hydrolyzed guar gum alleviates small intestinal mucosal damage after massive small bowel resection along with changes in the intestinal microbiota.  PMID: 31515113
   Weight
  • Obesity and Risk of Small Intestine Bacterial Overgrowth: A Systematic Review and Meta-Analysis.  PMID: 31605277 
  • Effect of eradicating hydrogen-forming small intestinal bacterial overgrowth with rifaximin on body weight change.  PMID: 31861004
 

Associated Conditions
 
   Anorexia Nervosa  NEW
  • Microbiota, Microbial Metabolites, and Barrier Function in A Patient with Anorexia Nervosa after Fecal Microbiota Transplantation.  PMID: 31510101
   Anxiety/Depression
  • 858 – Therapeutic Response to Small Intestinal Bacterial Overgrowth (SIBO) in Irritable Bowel Syndrome (IBS). is It Useful to Test For?.  DOI: 10.1016/S0016-5085(19)37267-1
   Brain Fog
  • Mo1610 – Characterizing Symptoms of Brain Fogginess and Its Association with D-Lactic Acidosis and Sibo.  DOI: 10.1016/S0016-5085(19)38954-1
   Cancer  NEW
  • Clinical evaluation and treatment of chronic bowel symptoms following cancer in the colon and pelvic organs.  PMID: 30698052
  • Association between small intestinal bacterial overgrowth and toll-like receptor 4 in patients with pancreatic carcinoma and cholangiocarcinoma.  PMID: 30457560
  • Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis.  DOI:10.1016/j.hbpd.2018.11.002
  • Relationship of TLR2 and TLR4 expressions on the surface of peripheral blood mononuclear cells to small intestinal bacteria overgrowth in patients with hepatocellular carcinoma.  PMID: 31082340
   Celiac Disease
  • METABOLIC ALTERATIONS IN CELIAC DISEASE OCCURRING AFTER FOLLOWING A GLUTEN-FREE DIET.  DOI: 10.1159/000495749
   Children (Pediatrics)
  • Impact of Small Intestine Bacterial Overgrowth on Response to a Nutritional Intervention in Bangladeshi Children from an Urban Community.  PMID: 30479249
  • Small Intestinal Bacterial Overgrowth in Children: A State-Of-The-Art Review.  PMID: 31552207
  • Increased Fecal Lactobacillus Is Associated With a Positive Glucose Hydrogen Breath Test in Bangladeshi Children.  PMID: 31281862
  • Monitoring of long-term parenteral nutrition in children with intestinal failure.  PMID: 31061893
  • Gastrointestinal Conditions in Children With Severe Feeding Difficulties.  PMID: 31020010
  • Long-term outcomes of ultrashort bowel syndrome due to malrotation with midgut volvulus managed at an interdisciplinary pediatric intestinal rehabilitation center.  PMID: 30826119
  • Risk Factors of Ambulatory Central Line-Associated Bloodstream Infection in Pediatric Short Bowel Syndrome.  PMID: 31179578
  • Small intestinal bacterial overgrowth: could it be associated with chronic abdominal pain in children with allergic diseases?  PMID: 31617366
  • Small intestinal bacterial overgrowth in children with intestinal failure on home parenteral nutrition.  PMID: 31633044
   Cholangitis  NEW
  • A Mechanistic Insight Into the Role of Gut Microbiota in the Pathogenesis of Primary Sclerosing Cholangitis.  DOI:10.1053/j.gastro.2019.10.012
   Cystic Fibrosis
  • Gut reaction: impact of systemic diseases on gastrointestinal physiology and drug absorption.  DOI: 10.1016/j.drudis.2018.11.009
   Diabetes
  • Diabetes and the gastrointestinal tract. DOI: 10.1016/j.mpmed.2019.04.011
   Diverticular Disease
  • Overview on the management of diverticular disease by Italian General Practitioners.  DOI: 10.1016/j.dld.2018.07.015
  •  A Set Up for SIBO.  PMID: 30639676
   Environmental Enteric Dysfunction
  • Environmental enteric dysfunction and growth.  PMID: 30629923
   Gallbladder Disease
  • High occurrence of small intestinal bacterial overgrowth in primary biliary cholangitis.  PMID: 31373141
   GERD
  • Beneficial effect of probiotics supplements in reflux esophagitis treated with esomeprazole: A randomized controlled trial.  PMID31114137
   Heart Failure
  • Hydrogen- and Methane-Based Breath Testing and Outcomes in Patients With Heart Failure.  DOI: 10.1016/j.cardfail.2018.10.004
  • Impact of intestinal microbiota in patients with heart failure: A systematic review.  DOI: 10.1016/j.medcle.2019.06.017
   Inflammatory Bowel Disease
  • Gastrointestinal motility and absorptive disorders in patients with inflammatory bowel diseases: Prevalence, diagnosis and treatment.  PMID: 31496621
  • Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease.  PMID: 30735254
  • Breath Test Gas Patterns in Inflammatory Bowel Disease with Concomitant Irritable Bowel Syndrome-Like Symptoms: A Controlled Large-Scale Database Linkage Analysis. PMID: 31754993
  • Bariatric Surgery and Its Complications in Inflammatory Bowel Disease Patients.  PMID: 31626698
   Intestinal Failure: Pediatric
  • Serum Unconjugated Bile Acids and Small Bowel Bacterial Overgrowth in Pediatric Intestinal Failure: A Pilot Study.  PMID: 30035316
   Irritable Bowel Syndrome
  • Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea.  PMID: 31688023 
  • Small intestinal bacterial overgrowth is associated with Diarrhea-predominant irritable bowel syndrome by increasing mainly Prevotella abundance.  PMID: 31765575 
  • Breath Test Gas Patterns in Inflammatory Bowel Disease with Concomitant Irritable Bowel Syndrome-Like Symptoms: A Controlled Large-Scale Database Linkage Analysis. PMID: 31754993
  • A meta-analysis on small intestinal bacterial overgrowth in patients with different subtypes of irritable bowel syndrome.  PMID: 31750966 
  • Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome.  PMID: 31674052 
  • Irritable bowel syndrome and gut microbiota.  PMID: 31789724
   Liver Disease
  • Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease.  PMID:30915401
  • An assessment of bacterial overgrowth and translocation in the non-alcoholic fatty liver of patients with morbid obesity.  PMID: 30896956
  • The role of Small Intestinal Bacterial Overgrowth (SIBO) in Non-alcoholic Fatty Liver Disease (NAFLD) patients evaluated using Controlled Attenuation Parameter (CAP) Transient Elastography (TE): a tertiary referral center experience.  PMID: 30894137
  • Alcoholic liver disease and mast cells: What's your gut got to do with it?   https://doi.org/10.1016/j.livres.2019.02.002
  • Role of the intestinal microbiome in liver fibrosis development and new treatment strategies.  DOI: 10.1016/j.trsl.2019.02.005
  • Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis.  DOI:10.1016/j.hbpd.2018.11.002
  • An assessment of bacterial overgrowth and translocation in the non-alcoholic fatty liver of patients with morbid obesity.  PMID: 30896956
  • Su1083 – Small Intestinal Bacterial Overgrowth and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.  DOI: 10.1016/S0016-5085(19)40180-7
  • Mo2015 – The Role of Small Intestinal Bacteria Overgrowth in Nonalcoholic Fatty Liver Disease.  DOI: 10.1016/S0016-5085(19)39278-9
  • Is small intestinal bacterial overgrowth a cause of hyperdynamic circulation in cirrhosis?  PMID: 31767551
   Metabolic Syndrome
  • The relationship between vitamin C status, the gut-liver axis, and metabolic syndrome.  DOI: 10.1016/j.redox.2018.101091
   Obesity (morbid)
  • An assessment of bacterial overgrowth and translocation in the non-alcoholic fatty liver of patients with morbid obesity.  PMID: 30896956
  • Mo2023 – Association Between Obesity and Risk of Small Intestine Bacterial Overgrowth: A Systematic Review and Metaanalysis.  DOI: 10.1016/S0016-5085(19)39287-X
  • Obesity and Risk of Small Intestine Bacterial Overgrowth: A Systematic Review and Meta-Analysis.  PMID: 31605277 
  • Effect of eradicating hydrogen-forming small intestinal bacterial overgrowth with rifaximin on body weight change.  PMID: 31861004
   Pancreatic Disease
  • Factors That Affect Prevalence of Small Intestinal Bacterial Overgrowth in Chronic Pancreatitis: A Systematic Review, Meta-Analysis, and Meta-Regression.  PMID: 31517648
  • Small Intestinal Bacterial Overgrowth Is Common in Chronic Pancreatitis and Associates With Diabetes, Chronic Pancreatitis Severity, Low Zinc Levels, and Opiate Use.  PMID: 31008737
  • Association between increased breath hydrogen methane concentration and prevalence of glucose intolerance in acute pancreatitis.  PMID: 31689699
  • Altered diversity and composition of gut microbiota in Chinese patients with chronic pancreatitis. DOI: 10.1016/j.pan.2019.11.013
   Parkinson’s Disease
  • Gut reaction: impact of systemic diseases on gastrointestinal physiology and drug absorption.  DOI: 10.1016/j.drudis.2018.11.009
  • Triggers, Facilitators, and Aggravators: Redefining Parkinson’s Disease Pathogenesis.  DOI:10.1016/j.tins.2018.09.007
  • Contributions of Gut Bacteria and Diet to Drug Pharmacokinetics in the Treatment of Parkinson's Disease.  PMID: 31681153
  • Bile acid abnormality induced by intestinal dysbiosis might explain lipid metabolism in Parkinson's disease.  PMID: 31678900
   Polyderma faciale NEW
  • Pyoderma faciale in a patient with small intestinal bacterial overgrowth.  PMID: 30968945
   Restless Legs Syndrome
  • Restless Leg Syndrome: Does It Start With A Gut Feeling? https://doi.org/10.1093/sleep/zsz067.008
   Sexual Dysfunction  NEW
  • Could problems in the bedroom come from our intestines? A preliminary study of IBS and its impact on female sexuality.  PMID: 31488791
   Short Bowel Syndrome
  • Long-term outcomes of ultrashort bowel syndrome due to malrotation with midgut volvulus managed at an interdisciplinary pediatric intestinal rehabilitation center.  PMID: 30826119
  • DPP4 inhibitor reinforces cell junction proteins in mouse model of short syndrome.  PMID: 31576468
  • Risk Factors of Ambulatory Central Line-Associated Bloodstream Infection in Pediatric Short Bowel Syndrome.  PMID: 31179578
   Surgery: Gastric By-pass/Bariatric
  • Impact of Oral-Cecal Transit Time on the Interpretation of Lactulose Breath Tests After RYGB: a Personalized Approach to the Diagnosis of SIBO.  PMID: 30627990
  • Gut Microbiota Imbalance Can Be Associated with Non-malabsorptive Small Bowel Shortening Regardless of Blind Loop.  PMID: 30293133
   Systemic Sclerosis
  • Prevalence and associated factors of small intestinal bacterial overgrowth among systemic sclerosis patients.  PMID: 30729669
  • Effectiveness of Saccharomyces boulardii and Metronidazole for Small Intestinal Bacterial Overgrowth in Systemic Sclerosis.  PMID: 31549334


Testing
  • Impact of Oral-Cecal Transit Time on the Interpretation of Lactulose Breath Tests After RYGB: a Personalized Approach to the Diagnosis of SIBO.  PMID: 30627990
  • Serum Unconjugated Bile Acids and Small Bowel Bacterial Overgrowth in Pediatric Intestinal Failure: A Pilot Study.  PMID: 30035316
  • Noninvasive Magnetogastrography Detects Erythromycin-Induced Effects on the Gastric Slow Wave.  PMID: 29993499 (MMC testing)
  • BREATH TESTS FOR SMALL INTESTINAL BACTERIAL OVERGROWTH DIAGNOSIS: A SYSTEMATIC REVIEW WITH META-ANALYSIS.  https://doi.org/10.1016/S1590-8658(19)30442-6
  • Second-Generation Biomarker Testing for Irritable Bowel Syndrome Using Plasma Anti-CdtB and Anti-Vinculin Levels. PMID: 31152332
  • Gastric, small bowel and colonic motility and breath-testing.  DOI: 10.1016/j.mpmed.2019.03.006
  • First Large Scale Study Defining the Characteristic Microbiome Signatures of Small Intestinal Bacterial Overgrowth (SIBO): Detailed Analysis from the Reimagine Study.  DOI: 10.1016/S0016-5085(19)36776
  • Su1949 – Small Intestinal Aspirates Require Specific Treatment to Optimize Microbial Analysis: Validation of a Novel Technique from the Reimagine Study  DOI: https://doi.org/10.1016/S0016-5085(19)38583-X
  • Sa1912 – Revealing the Entire Intestinal Microbiota and Its Associations to the Genetic, Immunologic, and Neuroendocrine Ecosystems: Methodology for the Reimagine Study.  DOI: https://doi.org/10.1016/S0016-5085(19)37978-8
  • P.06.12 BREATH TESTS FOR SMALL INTESTINAL BACTERIAL OVERGROWTH DIAGNOSIS: A SYSTEMATIC REVIEW WITH META-ANALYSIS.  DOI: 10.1016/S1590-8658(19)30442-6
  • Tu1873 – Bowel Cleansing May Affect Diagnostic Yield of Small Bowel Aspirates for Diagnosis of Sibo in Patients with Diarrhea.  DOI: 10.1016/S0016-5085(19)39856-7
  • Tu1600 – Air Or Carbon Dioxide Insufflation in Upper Endoscopies and the Yield of Quantitative Small Bowel Aspirate Cultures.  DOI: 10.1016/S0016-5085(19)39605-2
  • Sa1953 – Pictograms are Highly Effective for Diagnosing Abdominal Bloating and Distension in Patients with Irritable Bowel Syndrome (IBS).  DOI: 10.1016/S0016-5085(19)38019-9
  • Su1949 – Small Intestinal Aspirates Require Specific Treatment to Optimize Microbial Analysis: Validation of a Novel Technique from the Reimagine Study.  DOI: 10.1016/S0016-5085(19)38583-X
  • Changes in Fecal Calprotectin After Rifaximin Treatment in Patients With Nonconstipated Irritable Bowel Syndrome.  DOI: 10.1016/j.amjms.2018.11.004.
  • Reaction of antibodies to Campylobacter jejuni and cytolethal distending toxin B with tissues and food antigens.  PMID: 30862994
  • Zonulin in serum as a biomarker fails to identify the IBS, functional dyspepsia and non-coeliac wheat sensitivity.  PMID: 31563879
  • Characterization of Proximal Small Intestinal Microbiota in Patients With Suspected Small Intestinal Bacterial Overgrowth: A Cross-Sectional Study.  PMID: 3146469
  • Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders.  PMID: 31043597
  • Optimizing microbiome sequencing for small intestinal aspirates: validation of novel techniques through the REIMAGINE study.  PMID: 31675917
  • Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea.  PMID: 31688023
  • Carbohydrate Intolerance and Disaccharidase Measurement - a Mini-Review.  PMID: 31857738
  • Diagnostic Utility of Carbohydrate Breath Tests for SIBO, Fructose, and Lactose Intolerance.  PMID: 31617133
  • Breath Test Gas Patterns in Inflammatory Bowel Disease with Concomitant Irritable Bowel Syndrome-Like Symptoms: A Controlled Large-Scale Database Linkage Analysis. PMID: 31754993
  • Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome.  PMID: 31674052
  • Breath Tests for the Non-invasive Diagnosis of Small Intestinal Bacterial Overgrowth: A Systematic Review With Meta-analysis.  PMID: 31743632

Methane
  • Tu1887 – Patients with Appendectomy Have Significantly Less Methane in Their Exhaled Breath: is the Appendix a Vestigial Organ Or an Important Reservoir for Methanogens?  doi: 10.1016/S0016-5085(19)39870-1
  • Tu1897 – Enteric Methane Or Hydrogen Production in Patients with Unexplained Gastrointestinal Symptoms: Associations with Age, Symptoms and Proton Pump Inhibitors  doi: 10.1016/S0016-5085(19)39880-4
  • Su1635 – Oral Iron Supplementation, Microbiome Related Methanogenesis and Constipation - a Novel Model to Explain and Age Old Problem  doi: 10.1016/S0016-5085(19)38374-X


Hydrogen Sulfide
  • SIBO AS AN ADAPTATION: A PROPOSED ROLE FOR HYDROGEN SULFIDE NDNR
  • Sa1918 – Jejunal But Not Colonic Hydrogen Sulfide Increased Portal Blood Flow But Not Portal Pressure.  DOI: 10.1016/S0016-5085(19)37984-3
  • Breath Test Gas Patterns in Inflammatory Bowel Disease with Concomitant Irritable Bowel Syndrome-Like Symptoms: A Controlled Large-Scale Database Linkage Analysis. PMID: 31754993
 
 
Treatment 
  • Management of Small Intestinal Bacterial Overgrowth in Adult Patients.  PMID: 31145251

   Antibiotics
  • Effectiveness of Saccharomyces boulardii and Metronidazole for Small Intestinal Bacterial Overgrowth in Systemic Sclerosis.  PMID: 31549334
  • Effect of Rifaximin Treatment on Endotoxemia and Insulin Sensitivity in Humans.  PMID: 31428718
  • Changes in Fecal Calprotectin After Rifaximin Treatment in Patients With Nonconstipated Irritable Bowel Syndrome.  DOI: 10.1016/j.amjms.2018.11.004.
  • Su1589 – Predictive Factors of Response to Rifaximin in Irritable Bowel Syndrome and Bacterial Overgrowth.  DOI: 10.1016/S0016-5085(19)38328-3
  • 444 – Rifaximin for Improving Abdominal Pain and Bloating Symptoms in Patients with Irritable Bowel Syndrome with Diarrhea (IBS-D) Using Modified Definitions of Pain Response.  DOI: 10.1016/S0016-5085(19)37017-9
  • Mo1545 – Characterization of Abdominal Pain Response to Rifaximin in Patients with Irritable Bowel Syndrome with Diarrhea (IBSD), by Baseline Pain Severity
  • Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea.  PMID: 31688023
   
  
Bacteriophage  NEW
  • Transplanting Fecal Virus-Like Particles Reduces High-Fat Diet-Induced Small Intestinal Bacterial Overgrowth in Mice.  PMID: 31750259
  Prokinetics
  • Rikkunshito Depolarizes Pacemaker Potentials of Cultured Interstitial Cells of Cajal through Ghrelin Receptors in Murine Small Intestine.  PMID: 30889598
  • Prucalopride for the treatment of constipation: a view from 2015 and beyond.  PMID:30791758
  • Prucalopride, A Recently Approved Drug by the Food and Drug Administration for Chronic Idiopathic Constipation.  PMID: 30820411
  • The effect of pyridostigmine on small intestinal bacterial overgrowth(SIBO) and plasma inflammatory biomarkers in HIV-associated autonomic neuropathies.  PMID: 31098925
  • Mo1584 – Effectiveness of Lanreotide in the Treatment of Patients with Small Bowel Motility Disorder (SBMD).  DOI: 10.1016/S0016-5085(19)38928-0
  • In brief: Tegaserod (Zelnorm) returns.  PMID: 31169806
  • Prucalopride (Motegrity) for chronic idiopathic constipation.  PMID: 31170120
  • Clinical Efficacy and Safety Profile of Prucalopride in Chronic Idiopathic Constipation.  PMID: 31218146
  • Study Design and Cohort Comparability in a Study of Major Cardiovascular Events in New Users of Prucalopride Versus Polyethylene Glycol 3350.  PMID: 31134513
  • Cardiovascular Safety of Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort Study.  PMID: 31134512
  • Use of prucalopride in adults with chronic idiopathic constipation.  PMID: 31096799

  Probiotics
  • Effectiveness of Saccharomyces boulardii and Metronidazole for Small Intestinal Bacterial Overgrowth in Systemic Sclerosis.  PMID: 31549334
  • Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth.  PMID: 29508268
  • Sa1936 – Efficacy and Safety of Saccharomyces Boulardii Cncm I -745 in the Treatment of Small Intestinal Bacterial Overgrowth in Patients Suffering Irritable Bowel Syndrome with Diarrhea.  DOI: 10.1016/S0016-5085(19)38002-3
  • Mo1543 – The Effect of Low Fodmap Diet Management in Combination with Bifidobacteria on IBS Patients in Western China:A Prospective Randomized Trail.  DOI: 10.1016/S0016-5085(19)38887-0
  • Beneficial effect of probiotics supplements in reflux esophagitis treated with esomeprazole: A randomized controlled trial.  PMID31114137
  
  Acupuncture
  • Acupuncture protects the interstitial cells of Cajal by regulating miR-222 in a rat model of post-operative ileus.  PMID: 30852906
  • Ameliorating Effects of Electroacupuncture on Dysmotility, Inflammation and Pain Mediated via the Autonomic Mechanism in a Rat Model of Postoperative Ileus.  PMID: 30827069

  Fecal Microbiota Transplantation (FMT)
  • Microbiota, Microbial Metabolites, and Barrier Function in A Patient with Anorexia Nervosa after Fecal Microbiota Transplantation.  PMID: 31510101
  • Tu1878 – Fecal Microbiota Transplantation (FMT) in Irritable Bowel Syndrome (IBS): A Systematic Review and Meta-Analysis.  DOI: 10.1016/S0016-5085(19)39861-

  Diet
  • Role of Dietary Lipids in Modulating Inflammation through the Gut Microbiota.  PMID: 30626117
  • The Dietary Management of Patients with Irritable Bowel Syndrome: A Narrative Review of the Existing and Emerging Evidence.  PMID: 31505870
  • The role of diet in irritable bowel syndrome: implications for dietary advice.  PMID: 31468640
  • Reaction of antibodies to Campylobacter jejuni and cytolethal distending toxin B with tissues and food antigens.  PMID: 30862994 
  • Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders.  PMID: 31043597
  • The Dietary Management of Patients with Irritable Bowel Syndrome: A Narrative Review of the Existing and Emerging Evidence.  PMID: 31505870
  • The role of diet in irritable bowel syndrome: implications for dietary advice.  PMID: 31468640
  • Reaction of antibodies to Campylobacter jejuni and cytolethal distending toxin B with tissues and food antigens.  PMID: 30862994 
 
  FODMAP Diet
  • Tolerability of FODMAP - reduced diet in irritable bowel syndrome - efficacy, adherence, and body weight course.  PMID: 30873577
  • Joint Hypermobility Syndrome Affects Response to a Low Fermentable Oligosaccharide, Disaccharide, Monosaccharide and Polyol Diet in Irritable Bowel Syndrome Patients: A Retrospective Study.  PMID: 30834032
  • Self-reported Food Intolerance in Korean Patients With Irritable Bowel Syndrome.  PMID: 30827068
  • REPLY TO THE LETTER: Prebiotics Versus Low Fodmap Diet: An Interpretative Nightmare.  PMID: 30794765
  • Exit Gluten-Free and Enter Low FODMAPs: A Novel Dietary Strategy to Reduce Gastrointestinal Symptoms in Athletes.  PMID: 30671907
  • Effect of a short-term low fermentable oligiosaccharide, disaccharide, monosaccharide and polyol (FODMAP) diet on exercise-related gastrointestinal symptoms.  PMID: 30646926
  • Low-FODMAP Diet Is Associated With Improved Quality of Life in IBS Patients-A Prospective Observational Study.  PMID: 30644587
  • Review article: implementation of a diet low in FODMAPs for patients with irritable bowel syndrome-directions for future research.  PMID: 30589971
  • Adherence with a low-FODMAP diet in irritable bowel syndrome: are eating disorders the missing link?  PMID: 30543574
  • The Effect of Diet on Irritable Bowel Syndrome Symptoms and Its Role in the Treatment Plan (P12-001-19).  PMID: 31224179
  • How Patients with IBS Use Low FODMAP Dietary Information Provided by General Practitioners and Gastroenterologists: A Qualitative Study.  PMID: 31205130
  • Influence of Dietary Fiber in Low FODMAP Diet for Irritable Bowel Syndrome.  PMID: 31205130
  • EVALUATION OF CARBOHYDRATE AND FIBER CONSUMPTION IN PATIENTS WITH IRRITABLE BOWEL SYNDROME IN OUTPATIENT TREATMENT.  PMID: 31141064
  • The Impact of a 4-Week Low-FODMAP and mNICE Diet on Nutrient Intake in a Sample of US Adults with Irritable Bowel Syndrome with Diarrhea.  PMID: 31103370
  • Specific foods can reduce symptoms of irritable bowel syndrome and functional constipation: a review.  PMID: 31080496
  • Low fermentable oligosaccharides, disaccharides, monosaccharides, and polypols diet and irritable bowel syndrome in Asia.  PMID: 31061894
  • Nutrient Intake, Diet Quality, and Diet Diversity in Irritable Bowel Syndrome and the Impact of the Low FODMAP Diet.  PMID: 31029650
  • Elimination of Fermentable Carbohydrates to Reduce Gastrointestinal Symptoms in Pediatric Patients With Irritable Bowel Syndrome: A Narrative Review.  PMID: 30937981
  • Probiotics, prebiotics, and low FODMAP diet for irritable bowel syndrome - What is the current evidence?  PMID: 30935559
  • Tolerability of FODMAP - reduced diet in irritable bowel syndrome - efficacy, adherence, and body weight course.  PMID: 30873577
  • Low FODMAPs diet for functional abdominal pain disorders in children: critical review of current knowledge.  DOI: 10.1016/j.jped.2019.03.004
  • Sa1942 – Real-World Implementation of the Low Fodmap Diet: Poor Compliance is Significantly Improved by Guidance from a Dietitian.  DOI: 10.1016/S0016-5085(19)38008-4
  • Su1580 – A Longitudinal Study Examining the Effect of Altering Fodmap Intake on the Metabolome and Pain Signaling in IBS Patients.  DOI: 10.1016/S0016-5085(19)38319-2
  • Mo1543 – The Effect of Low Fodmap Diet Management in Combination with Bifidobacteria on IBS Patients in Western China:A Prospective Randomized Trail.  DOI: 10.1016/S0016-5085(19)38887-0
  • 860 – Low Fodmap Diet in the Long Term: Efficacy, Acceptability and Individual Perception of Trigger Foods. A Pilot Study.  DOI: 10.1016/S0016-5085(19)37269
  • 347 – Is Sucrose the Sixth Fodmap in a Subset of Patients with Irritable Bowel Syndrome with Diarrhea and Sucrase Isomaltase Deficiency?.  DOI: 10.1016/S0016-5085(19)36959-8
  • Mo1548 – Efficacy, Feasibility, and Safety of the Low Fodmap Diet for Children with Irritable Bowel Syndrome: A Prospective Cohort Study and Phone Survey.  DOI: 10.1016/S0016-5085(19)38892-4
  • Sa1958 – Measuring Diet Intake and Gastrointestinal Symptoms in Irritable Bowel Syndrome: Validation of the Food and Symptom Times (FAST) Diary with Fodmap Analysis.  DOI: 10.1016/S0016-5085(19)38024
  • Controversies and reality of the FODMAP diet for patients with irritable bowel syndrome.  PMID: 30945376
  • Bacillus spp. Spores-A Promising Treatment Option for Patients with Irritable Bowel Syndrome.  PMID: 31438618
  • Is Bacillus coagulans supplementation plus low FODMAP diet superior to low FODMAP diet in irritable bowel syndrome management?  PMID: 31327047
  • Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition.  PMID: 31591348
  • Effects of Low-FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial.  PMID: 31586453
  • Implementation of the low FODMAP diet in functional gastrointestinal symptoms: A real-world experience.  PMID: 31571351
  • Commentary: Adherence with a low-FODMAP diet in irritable bowel syndrome: are eating disorders the missing link?  PMID: 31552257
  • Low FODMAP diet significantly improves IBS symptoms: an Irish retrospective cohort study.  PMID: 31520160
  • Gluten and FODMAPS-Sense of a Restriction/When Is Restriction Necessary?  PMID: 31434299
  • Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones.  PMID: 31394793
  • Effect of Three Diets (Low-FODMAP, Gluten-free and Balanced) on Irritable Bowel Syndrome Symptoms and Health-Related Quality of Life.  PMID: 31336747
  • Impaired cell surface expression and digestive function of sucrase-isomaltase gene variants are associated with reduced efficacy of low FODMAPs diet in patients with IBS-D.  PMID: 31331993
  • Irritable bowel syndrome: how can symptoms and quality of life be improved with diet?  PMID: 31313689
  • Review article: biological mechanisms for symptom causation by individual FODMAP subgroups - the case for a more personalised approach to dietary restriction.  PMID: 31309595
  • Influence of Dietary Fiber in Low FODMAP Diet for Irritable Bowel Syndrome.  PMID: 31205130
  • The gut microbiome as a predictor of low fermentable oligosaccharides disaccharides monosaccharides and polyols diet efficacy in functional bowel disorders.  PMID: 31850930
  • Technological Methods for Reducing the Content of Fructan in Wheat Bread.  PMID: 31835575
  • All that a physician should know about FODMAPs.  PMID: 31802437
  • Effect of Structural Individual Low-FODMAP Dietary Advice vs. Brief Advice on a Commonly Recommended Diet on IBS Symptoms and Intestinal Gas Production.  PMID: 31766497
  • Possible role of peptide YY (PYY) in the pathophysiology of irritable bowel syndrome (IBS).  PMID: 31727345
  • Literature Review: Dietary Intervention Adherence and Adherence Barriers in Functional Gastrointestinal Disorder Studies.  PMID: 31714332
  • The Pervasive Misunderstanding of What The FODMAP Diet Does And Does Not Do: Part 1.  Today’s Practitioner
  • The Pervasive Misunderstanding of What the FODMAP Diet Does and Doesn’t Do: Part 2.  Today’s Practitioner 
  • Impact of 24-hour high and low fermentable oligo- di- mono- saccharide polyol diets on markers of exercise-induced gastrointestinal syndrome in response to exertional-heat stress.  PMID: 31652404
  • The long-term effect and adherence of a low fermentable oligosaccharides disaccharides monosaccharides and polyols (FODMAP) diet in patients with irritable bowel syndrome. PMID: 31637777
  • Observational Study on Knowledge and Eating Habits with Respect to Low- and High-FODMAP Foods in Medical Checkup Populations in Japan.  PMID: 31614902
  • Hypothesis: Mechanism of irritable bowel syndrome in inflammatory bowel disease. PMID: 31421429
  • The impact of dietary fermentable carbohydrates on a postinflammatory model of irritable bowel syndrome.  PMID: 31290223
  • Low FODMAPs diet for functional abdominal pain disorders in children: critical review of current knowledge.  DOI: 10.1016/j.jped.2019.03.004
Powered by Create your own unique website with customizable templates.